/Magnifying%20glass%20and%20analytics%20documents%20by%20tonefotografia%20via%20Adobe%20Stock.jpeg)
Norwalk, Connecticut-based FactSet Research Systems Inc. (FDS) operates as a financial data and analytics platform and enterprise solutions provider for the investment community. Valued at a market capitalization of $8.7 billion, the company offers data, products, and analytical applications, as well as workstations, portfolio analytics, and enterprise data solutions, along with managed services to support data, performance, and risk.
Companies with a market cap of $10 billion or more are typically referred to as “big-cap stocks.” FDS fits right into that category, with its market cap exceeding this threshold, reflecting its substantial size and influence in the Financial Data & Stock Exchanges industry.
Despite its strength, FDS stock slipped 49.7% from its 52-week high of $453.41, reached on July 14, 2025. The stock is up 9.2% over the past three months, underperforming the S&P 500 Index’s ($SPX) 10.5% rise during the same time frame.
Moreover, FDS has lagged behind the broader market over the longer term. The stock has declined 46.1% over the past 52 weeks, while SPX has delivered a 24% return over the same period.
FDS has been trading mostly below its 200-day moving average since last year and below its 50-day moving average since the last trading session.
On Mar. 31, FDS stock rose 6.1% following the release of its Q2 2026 earnings. The company’s revenue for the quarter came in at $611 million, surpassing Wall Street’s estimates. Moreover, its adjusted EPS amounted to $4.46, also coming in on top of the Street’s forecasts. FactSet expects full-year earnings in the range of $17.25 to $17.75 per share, with revenue in the range of $2.45 billion to $2.47 billion.
When stacked against its peer, TransUnion (TRU), FDS has underperformed. Over the past year, TRU stock has declined 24.1%.
Wall Street currently has a skeptical view of the stock. Among the 17 analysts tracking FDS, the overall consensus stands at a “Hold.” Its mean price target of $260.44 offers a 14.1% upside potential from current prices.
.jpeg?w=600)
